QUICK LINKS
In September we saw a much-anticipated cut in the US Federal Funds rate of 50bps with Federal Reserve Committee minutes mentioning confidence that inflation is moving sustainably towards the 2% target. Outside of the US, China announced a slew of prospective stimulus measures to revitalise their economy. We were encouraged by the commitment toward even further accommodative monetary policy measures in China and the subsequent market reaction. However, we are waiting for more tangible evidence of a sustainable recovery in economic growth given the soft credit uptake we have seen thus far. Policies aimed at restoring consumer confidence, addressing the credit profile in the property sector and encouraging a sustainable turnaround in credit extension will go a long way in lifting potential economic growth. Overall, the Bloomberg World Index gained 2%, while the Ashburton Global Leaders Fund (I Class USD) was 0.6%.
Ping An, a Chinese insurance company, which is highly leveraged to the Chinese stock market was up 38.6% and Alibaba, a Chinese ecommerce company with a cloud business, was up 38.6%. Home Depot also had a positive month rising 10% as the company was a beneficiary of lower interest rates.
On the negative side, Samsung Electronics was down 14.9% due to weaker DRAM and NAND prices. The weakness is being driven by sluggish demand for PCs and smartphones. We believe this is a near term headwind and that Samsung Electronics will benefit as a supplier of High Bandwidth Memory (HBM) products which support higher processing speed for AI servers where demand remains robust. The HBM market is expected to grow substantially over the next few years due to AI investments by cloud service providers and rising demand for AI in enterprise on-premises servers. Samsung is currently trading below a 1.0x price to book ratio which is significantly below its long-term average of c1.3x reflecting the markets fears of an imminent memory downturn. However, along with Samsung’s near historical low capital intensity, we expect tighter DRAM capacity, robust HBM demand and a replacement cycle in PCs and smartphones (AI devices to have higher memory content) to support pricing even if there is short term weakness.
AstraZeneca was down 10.9% in the month. The weakness was due to the results in a late-stage lung cancer drug that the company is developing with Daiichi Sankyo showing disappointing results which may mean delays in Food and Drug Administration approval. However, the company has multiple pipeline catalysts with staggered patent expiries, and we remain positive that it can still reach its US$80bn annual revenue target by 2030.
JP Morgan was down 6.2% after management mentioned at a conference that the number for expenses that analysts are expecting for next year are a bit too optimistic due to inflation and some investments.
Heightened geopolitical tensions, the US elections and China stimulus or lack therefore of are likely to be shorter term market drivers into Q4. However, with a recent positive US jobs report, inflation moving in the right direction and comments by JP Morgan suggesting the bank is not seeing a consumer under stress, increasingly support the notion of a soft landing.
Disclaimer:
Waystone Management Company (Lux) S.A. is regulated by the Commission de Surveillance du Secteur Financier (CSSF) (ref A00000395 & S00000734), Waystone Management Company (Lux) S.A. is a company located in Luxembourg, L-1273 Luxembourg at 19, Rue de Bitbourg. This document is Issued by Ashburton Fund Managers (Pty) Limited (The Investment Manager) (Reg number 2002/013187/07), which has its registered office at 3 Merchant Place, 1 Fredman Drive, Sandton, 2196, South Africa and is an authorised financial services provider (FSP number 40169), registered with the Financial Sector Conduct Authority (FSCA). Global Leaders Equity Fund and Global Equity Growth Fund are authorised in Luxembourg and regulated by the Commission de Surveillance du Secteur Financier (CSSF). In South Africa, the Fund(s) is/are approved for promotion under section 65 of the Collective Investment Schemes Control Act 2002. The Fund Prospectus, and further information including pricing and changes, may be viewed at the Fund’s representative office in South Africa: Ashburton Management Company (RF) Proprietary Limited (“Ashburton CIS”), of the same address. Ashburton CIS is an approved collective investment schemes manager regulated by the Financial Sector Conduct Authority and a full member of the Association of Saving and Investments South Africa. In the event a potential investor requires material risks disclosures for the foreign securities included in a portfolio, the manager will upon request provide such potential investor with a document, outlining potential constraints on liquidity & repatriation of funds; Macroeconomics risk; Political risk; Foreign Exchange risk; Tax risk; Settlement risk; and Potential limitations on the availability of market information. The value of participatory interests and the income from them may go down as well as up and is not guaranteed. Past performance is not necessarily a guide to the future performance. Where an investment involves exposure to a currency other than that in which it is denominated, changes in rates of exchange may cause the value of the investment to go up or down.
CIS portfolios are traded at ruling prices and can engage in borrowing and scrip lending. A full detailed schedule of fees, charges and commissions is available from Ashburton on request and incentives may be paid and if so, would be included in the overall costs. The manager does not provide any guarantee either with respect to the capital or the return of a portfolio. The manager has a right to close the portfolio to new investors in order to manage the portfolio more efficiently in accordance with its mandate. This document does not constitute an offer or solicitation to any person in any jurisdiction in which Ashburton Fund Managers (Pty) Limited is not authorised or permitted to communicate with potential investors, or to anyone who would be an unlawful recipient. The original recipient is solely responsible for any actions in further distribution of this document and should be satisfied in doing so that there is no breach of local legislation or regulations. This is a marketing communication. The Management company has the right to terminate the arrangements made for Marketing.
Additional information about this product, including brochures, prices, application forms, Prospectus, KIID and annual or half-yearly reports, can be obtained from the Manager, free of charge, and from the website: www.ashburtoninvestments.com. Any reference to ‘partner’ and/or ‘partnership’, shall be with respect to the commercial collaboration between Morgan Stanley Investment Management Limited, FirstRand Limited and Ashburton Investments. It is not the intention of these parties to create a legal partnership.
The content or fund you have selected is not available for the profile or region you have selected. Please select one of the options below to return to the site.